Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04228796 · ClinicalTrials.gov registry record
Analysis of Biomarkers in Lymph Node Tissue
A clinical trial of Analysis of Biomarkers in Lymph Node Tissue, sponsored by Mayo Clinic.
- Active
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT04228796: Active study of Analysis of Biomarkers in Lymph Node Tissue, sponsored by Mayo Clinic.
NCT04228796 is a study of Analysis of Biomarkers in Lymph Node Tissue that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04228796, a study of Analysis of Biomarkers in Lymph Node Tissue, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are doing an exploratory analysis of biomarkers to correlate with treatment outcome of transplant surgery.
Primary Outcome
Immunohistochemistry (IHC) for the LYVE1, VEGFR3 expression, VEGF-A/C/D, Ki-67, MMP-9 and TIMP-1
Conditions Studied
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2020-01-06 |
| Est. Completion | 2029-01 |
What the registry record for NCT04228796 still lists
NCT04228796 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Analysis of Biomarkers in Lymph Node Tissue appearing as the primary indexed condition, and to 0 interventions.
NCT04228796 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04228796 about?
NCT04228796 is a clinical study titled "Analysis of Biomarkers in Lymph Node Tissue". Researchers are doing an exploratory analysis of biomarkers to correlate with treatment outcome of transplant surgery.
What is the current status of trial NCT04228796?
This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2020-01-06. Estimated completion is 2029-01.
What conditions does trial NCT04228796 study?
This clinical trial studies the following conditions: Analysis of Biomarkers in Lymph Node Tissue.
Who is sponsoring clinical trial NCT04228796?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04228796 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI